top of page
we generate evidence to impact clinical practice and global health
We are registered with the Chamber of Commerce of Bogotá, and our research group was recognized in the 2021 call number 984 by the Ministry of Science, Technology, and Innovation of Colombia
Our work Ketorolac as a promising preventive measure for retinopathy of prematurity progression will be presented at the 39th World Ophthalmology Congress (WOC 2024) of the International Council of Ophthalmology in Vancouver, Canada in August.
Ongoing Projects
Publish with microscopIA
Our Publications
bottom of page